Cite
Wu L, Guo H, Sun H, et al. UNC119 mediates gambogic acid-induced cell-cycle dysregulation through the Gsk3β/β-catenin pathway in hepatocellular carcinoma cells. Anticancer Drugs. 2016;27(10):988-1000doi: 10.1097/CAD.0000000000000416.
Wu, L., Guo, H., Sun, H., Zhang, W., Sun, C., & Wang, J. (2016). UNC119 mediates gambogic acid-induced cell-cycle dysregulation through the Gsk3β/β-catenin pathway in hepatocellular carcinoma cells. Anti-cancer drugs, 27(10), 988-1000. https://doi.org/10.1097/CAD.0000000000000416
Wu, Lili, et al. "UNC119 mediates gambogic acid-induced cell-cycle dysregulation through the Gsk3β/β-catenin pathway in hepatocellular carcinoma cells." Anti-cancer drugs vol. 27,10 (2016): 988-1000. doi: https://doi.org/10.1097/CAD.0000000000000416
Wu L, Guo H, Sun H, Zhang W, Sun C, Wang J. UNC119 mediates gambogic acid-induced cell-cycle dysregulation through the Gsk3β/β-catenin pathway in hepatocellular carcinoma cells. Anticancer Drugs. 2016 Nov;27(10):988-1000. doi: 10.1097/CAD.0000000000000416. PMID: 27669172.
Copy
Download .nbib